Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency.
Although several genetic defects are known to impair oxidative microbicidal/cytotoxic mechanisms in human PMN, no deficiencies of PMN granule components that mediate oxygen-independent microbicidal activity have yet been reported. We analyzed PMN from patients with various granulocyte disorders for their content of two azurophil granule constituents, defensins and cathepsin G, that exert microbicidal/cytotoxic activity in vitro, and one component, elastase, that has ancillary microbicidal/cytotoxic activity. PMN from two (of two) patients with specific granule deficiency (SGD) displayed an almost complete deficiency of defensins, which in normal cells constitute greater than 30% of the protein content of azurophil granules. The SGD PMN contained normal or mildly decreased amounts of cathepsin G and elastase. Conversely, the PMN of three (of three) patients with Chediak-Higashi syndrome (CHS) substantially lacked cathepsin G and elastase, but their defensin content was normal or mildly decreased. Both CHS and SGD patients suffer from frequent and severe bacterial infections, and CHS patients frequently develop an atypical lymphoproliferative syndrome. The profound deficiency of PMN components with microbicidal/cytotoxic activity in SGD and CHS may contribute to the clinical manifestations of these disorders.
Ganz
T
T
Will Rogers Institute Pulmonary Research Laboratory, University of California, Los Angeles 90024.
Metcalf
J A
JA
Gallin
J I
JI
Boxer
L A
LA
Lehrer
R I
RI
D001770:Blood Bactericidal Activity; D001798:Blood Proteins / Q000302:isolation & purification; D056649:Cathepsin G; D002403:Cathepsins / Q000302:isolation & purification; D002609:Chediak-Higashi Syndrome / Q000097:blood*; D003594:Cytoplasmic Granules / Q000032:analysis* / Q000502:physiology; D003603:Cytotoxins / Q000172:deficiency / Q000302:isolation & purification*; D023082:Defensins; D004591:Electrophoresis, Polyacrylamide Gel; D006105:Granulomatous Disease, Chronic / Q000097:blood*; D006801:Humans; D007118:Immunoassay; D009504:Neutrophils / Q000032:analysis* / Q000502:physiology; D010196:Pancreatic Elastase / Q000302:isolation & purification; D009195:Peroxidase / Q000172:deficiency; D012697:Serine Endopeptidases
D001798:Blood Proteins; D003603:Cytotoxins; D023082:Defensins; D009195:Peroxidase; D002403:Cathepsins; D012697:Serine Endopeptidases; C534094:CTSG protein, human; D056649:Cathepsin G; D010196:Pancreatic Elastase